These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 17987106)
1. Nitric oxide destabilizes Pias3 and regulates sumoylation. Qu J; Liu GH; Wu K; Han P; Wang P; Li J; Zhang X; Chen C PLoS One; 2007 Oct; 2(10):e1085. PubMed ID: 17987106 [TBL] [Abstract][Full Text] [Related]
2. Activity-Induced SUMOylation of Neuronal Nitric Oxide Synthase Is Associated with Plasticity of Synaptic Transmission and Extracellular Signal-Regulated Kinase 1/2 Signaling. Du CP; Wang M; Geng C; Hu B; Meng L; Xu Y; Cheng B; Wang N; Zhu QJ; Hou XY Antioxid Redox Signal; 2020 Jan; 32(1):18-34. PubMed ID: 31642335 [No Abstract] [Full Text] [Related]
3. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity. Sentis S; Le Romancer M; Bianchin C; Rostan MC; Corbo L Mol Endocrinol; 2005 Nov; 19(11):2671-84. PubMed ID: 15961505 [TBL] [Abstract][Full Text] [Related]
4. The SUMO-E3 ligase PIAS3 targets pyruvate kinase M2. Spoden GA; Morandell D; Ehehalt D; Fiedler M; Jansen-Dürr P; Hermann M; Zwerschke W J Cell Biochem; 2009 May; 107(2):293-302. PubMed ID: 19308990 [TBL] [Abstract][Full Text] [Related]
5. Protein inhibitor of activated STAT3 (PIAS3) protein promotes SUMOylation and nuclear sequestration of the intracellular domain of ErbB4 protein. Sundvall M; Korhonen A; Vaparanta K; Anckar J; Halkilahti K; Salah Z; Aqeilan RI; Palvimo JJ; Sistonen L; Elenius K J Biol Chem; 2012 Jun; 287(27):23216-26. PubMed ID: 22584572 [TBL] [Abstract][Full Text] [Related]
6. SUMOylation of Argonaute-2 regulates RNA interference activity. Josa-Prado F; Henley JM; Wilkinson KA Biochem Biophys Res Commun; 2015 Sep; 464(4):1066-1071. PubMed ID: 26188511 [TBL] [Abstract][Full Text] [Related]
7. Characterization of a novel posttranslational modification in neuronal nitric oxide synthase by small ubiquitin-related modifier-1. Watanabe M; Itoh K Biochim Biophys Acta; 2011 Jul; 1814(7):900-7. PubMed ID: 21545853 [TBL] [Abstract][Full Text] [Related]
8. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy. Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449 [TBL] [Abstract][Full Text] [Related]
9. PIAS3 interacts with ATF1 and regulates the human ferritin H gene through an antioxidant-responsive element. Iwasaki K; Hailemariam K; Tsuji Y J Biol Chem; 2007 Aug; 282(31):22335-43. PubMed ID: 17565989 [TBL] [Abstract][Full Text] [Related]
10. SUMO E3 ligases are expressed in the retina and regulate SUMOylation of the metabotropic glutamate receptor 8b. Dütting E; Schröder-Kress N; Sticht H; Enz R Biochem J; 2011 Apr; 435(2):365-71. PubMed ID: 21288202 [TBL] [Abstract][Full Text] [Related]
11. SUMOylation can regulate the activity of ETS-like transcription factor 4. Kaikkonen S; Makkonen H; Rytinki M; Palvimo JJ Biochim Biophys Acta; 2010 Aug; 1799(8):555-60. PubMed ID: 20637912 [TBL] [Abstract][Full Text] [Related]
12. AMPK induces PIAS3 mediated SUMOylation of E3 ubiquitin ligase Smurf1 impairing osteogenic differentiation and traumatic heterotopic ossification. Chen J; Dang YM; Liu MC; Gao L; Guan T; Hu A; Xiong L; Lin H Biochim Biophys Acta Mol Cell Res; 2024 Oct; 1871(7):119771. PubMed ID: 38844181 [TBL] [Abstract][Full Text] [Related]
13. The SUMO (Small Ubiquitin-like Modifier) Ligase PIAS3 Primes ATR for Checkpoint Activation. Wu CS; Zou L J Biol Chem; 2016 Jan; 291(1):279-90. PubMed ID: 26565033 [TBL] [Abstract][Full Text] [Related]
14. Knocking Down PIAS3 Reduces H Wang B; Qian W; Chen K; Li M; Du C Cell Biochem Biophys; 2024 Jun; 82(2):1381-1387. PubMed ID: 38733503 [TBL] [Abstract][Full Text] [Related]
15. Sumoylation of bZIP transcription factor NRL modulates target gene expression during photoreceptor differentiation. Roger JE; Nellissery J; Kim DS; Swaroop A J Biol Chem; 2010 Aug; 285(33):25637-44. PubMed ID: 20551322 [TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in the UBC9 and PIAS3 genes of the SUMO-conjugating system and breast cancer risk. Dünnebier T; Bermejo JL; Haas S; Fischer HP; Pierl CB; Justenhoven C; Brauch H; Baisch C; Gilbert M; Harth V; Spickenheuer A; Rabstein S; Pesch B; Brüning T; Ko YD; Hamann U Breast Cancer Res Treat; 2010 May; 121(1):185-94. PubMed ID: 19760037 [TBL] [Abstract][Full Text] [Related]
17. The interaction of Piasy with Trim32, an E3-ubiquitin ligase mutated in limb-girdle muscular dystrophy type 2H, promotes Piasy degradation and regulates UVB-induced keratinocyte apoptosis through NFkappaB. Albor A; El-Hizawi S; Horn EJ; Laederich M; Frosk P; Wrogemann K; Kulesz-Martin M J Biol Chem; 2006 Sep; 281(35):25850-66. PubMed ID: 16816390 [TBL] [Abstract][Full Text] [Related]
18. PIAS3 enhances the transcriptional activity of HIF-1α by increasing its protein stability. Nakagawa K; Kohara T; Uehata Y; Miyakawa Y; Sato-Ueshima M; Okubo N; Asaka M; Takeda H; Kobayashi M Biochem Biophys Res Commun; 2016 Jan; 469(3):470-6. PubMed ID: 26697750 [TBL] [Abstract][Full Text] [Related]
19. SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation. Wu R; Fang J; Liu M; A J; Liu J; Chen W; Li J; Ma G; Zhang Z; Zhang B; Fu L; Dong JT J Biol Chem; 2020 May; 295(19):6741-6753. PubMed ID: 32249212 [TBL] [Abstract][Full Text] [Related]
20. SUMOylation of hnRNP-K is required for p53-mediated cell-cycle arrest in response to DNA damage. Lee SW; Lee MH; Park JH; Kang SH; Yoo HM; Ka SH; Oh YM; Jeon YJ; Chung CH EMBO J; 2012 Nov; 31(23):4441-52. PubMed ID: 23092970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]